O'Mahony Deirdre, Peikarz Richard L, Bandettini W Patricia, Arai Andrew E, Wilson Wyndham H, Bates Susan E
Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Clin Lymphoma Myeloma. 2008 Aug;8(4):249-52. doi: 10.3816/CLM.2008.n.034.
Current literature suggests that the incidence of cardiac involvement by lymphoma as identified by autopsy varies widely, ranging from 8.7% to 20%. Historically, many cases might have been clinically undetected; however, improved imaging techniques increasingly identify cardiac involvement incidentally. In addition, newer agents resulting in improved cancer therapy outcomes might alter the prevalence and location of metastatic deposits to include more unusual disease sites, including intracardiac locations. We present 2 cases and a review of the literature.
当前文献表明,经尸检确定的淋巴瘤累及心脏的发生率差异很大,范围在8.7%至20%之间。从历史上看,许多病例可能在临床上未被发现;然而,改进的成像技术越来越多地偶然发现心脏受累情况。此外,导致癌症治疗效果改善的新型药物可能会改变转移灶的发生率和位置,使其包括更多不寻常的疾病部位,包括心脏内的部位。我们报告2例病例并对文献进行综述。